MetaADEDB 2.0 @ LMMD
Ortho Evra
(ISHXLNHNDMZNMC-VTKCIJPMSA-N)
Structure
SMILES
O/N=C/1\CC[C@H]2C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@]2(O)C#C)CC
Molecular Formula:
C21H29NO2
Molecular Weight:
327.460
Log P:
4.1437
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
52.82
CAS Number(s):
53016-31-2
Synonym(s)
1.
Ortho Evra
2.
Evra
3.
norelgestromin-ethinyl estradiol combination patch
External Link(s)
MeSHC511292
PubChem Compound9568628
BindingDB50103633
ChEBI135398
CHEMBLCHEMBL1200807
DrugCentral1959
KEGGdr:D05205
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1MetrorrhagiaFAERS: 2453US FAERS
2Pulmonary EmbolismFAERS: 1259US FAERS
3NauseaFAERS: 1013US FAERS
4Application site reactionFAERS: 980US FAERS
5Deep Vein ThrombosisFAERS: 907US FAERS
6Drug exposure during pregnancyFAERS: 799US FAERS
7HeadacheFAERS: 571US FAERS
8Product quality issueFAERS: 571US FAERS
9Inappropriate schedule of drug administrationFAERS: 540US FAERS
10ThrombosisFAERS: 517US FAERS
11Drug dose omissionFAERS: 436US FAERS
12VomitingFAERS: 364US FAERS
13Breast tendernessFAERS: 343US FAERS
14MenorrhagiaFAERS: 340US FAERS
15Wrong technique in drug usage processFAERS: 319US FAERS
16Abdominal PainFAERS: 285US FAERS
17Cerebrovascular accidentFAERS: 248US FAERS
18DizzinessFAERS: 244US FAERS
19Product adhesion issueFAERS: 172US FAERS
20Chest PainFAERS: 159US FAERS
21FatigueFAERS: 153US FAERS
22Unevaluable eventFAERS: 151US FAERS
23Product use issueFAERS: 148US FAERS
24Uterine spasmFAERS: 137US FAERS
25AlopeciaFAERS: 133US FAERS
26Pregnancy with contraceptive patchFAERS: 107US FAERS
27Myocardial InfarctionFAERS: 104US FAERS
28Application site pruritusFAERS: 100US FAERS
29Vaginal DischargeFAERS: 94US FAERS
30Back PainFAERS: 91US FAERS
31Adverse eventFAERS: 82US FAERS
32AcneFAERS: 80US FAERS
33PneumoniaFAERS: 80US FAERS
34Urinary tract infectionFAERS: 75US FAERS
35AstheniaFAERS: 68US FAERS
36Mood swingsFAERS: 68US FAERS
37PruritusFAERS: 65US FAERS
38PalpitationsFAERS: 63US FAERS
39Application site irritationFAERS: 62US FAERS
40PainFAERS: 62US FAERS
41Muscle CrampFAERS: 55US FAERS
42Skin irritationFAERS: 55US FAERS
43MalaiseFAERS: 53US FAERS
44AnxietyFAERS: 48US FAERS
45Application site painFAERS: 47US FAERS
46SyncopeFAERS: 47US FAERS
47Application site erythemaFAERS: 46US FAERS
48Drug administered at inappropriate siteFAERS: 46US FAERS
49TachycardiaFAERS: 46US FAERS
50Medication ErrorFAERS: 43US FAERS
51Pulmonary thrombosisFAERS: 43US FAERS
52Cardiac ArrestFAERS: 42US FAERS
53Pharmaceutical product complaintFAERS: 42US FAERS
54Cerebral InfarctionFAERS: 37US FAERS
55Cerebral ThrombosisFAERS: 37US FAERS
56Weight decreasedFAERS: 37US FAERS
57Application site rashFAERS: 35US FAERS
58ChloasmaFAERS: 35US FAERS
59Feeling abnormalFAERS: 35US FAERS
60ArthralgiaFAERS: 34US FAERS
61PregnancyFAERS: 33US FAERS
62Drug administration errorFAERS: 32US FAERS
63MyalgiaFAERS: 31US FAERS
64UrticariaFAERS: 30US FAERS
65HypersensitivityFAERS: 29US FAERS
66Drug ineffectiveFAERS: 27US FAERS
67DehydrationFAERS: 26US FAERS
68Visual disturbanceFAERS: 26US FAERS
69Breast engorgementFAERS: 25US FAERS
70ConstipationFAERS: 25US FAERS
71AsthmaFAERS: 24US FAERS
72Chest discomfortFAERS: 24US FAERS
73Therapeutic response unexpectedFAERS: 24US FAERS
74Pulmonary InfarctionFAERS: 23US FAERS
75Acute myocardial infarctionFAERS: 22US FAERS
76Emotional disorderFAERS: 22US FAERS
77HypotensionFAERS: 22US FAERS
78Retinal Vein OcclusionFAERS: 22US FAERS
79BronchitisFAERS: 21US FAERS
80Depressed moodFAERS: 21US FAERS
81Drug prescribing errorFAERS: 21US FAERS
82Incorrect drug administration durationFAERS: 21US FAERS
83PancreatitisFAERS: 21US FAERS
84Product packaging quantity issueFAERS: 21US FAERS
85Premenstrual syndromeFAERS: 20US FAERS
86DyspepsiaFAERS: 19US FAERS
87AnorexiaFAERS: 18US FAERS
88Expired product administeredFAERS: 18US FAERS
89SinusitisFAERS: 18US FAERS
90Ectopic PregnancyFAERS: 17US FAERS
91EmbolismFAERS: 17US FAERS
92Pericardial effusionFAERS: 16US FAERS
93VertigoFAERS: 16US FAERS
94Wrong technique in product usage processFAERS: 16US FAERS
95AphasiaFAERS: 15US FAERS
96Contact lens intoleranceFAERS: 15US FAERS
97NasopharyngitisFAERS: 15US FAERS
98Portal Vein ThrombosisFAERS: 15US FAERS
99Respiratory FailureFAERS: 15US FAERS
100Venous ThrombosisFAERS: 15US FAERS
101Ventricular FibrillationFAERS: 15US FAERS
102Application site scarFAERS: 14US FAERS
103AtelectasisFAERS: 14US FAERS
104InfluenzaFAERS: 14US FAERS
105TremorFAERS: 14US FAERS
106Application site burnFAERS: 13US FAERS
107ChillsFAERS: 13US FAERS
108CholelithiasisFAERS: 13US FAERS
109DysuriaFAERS: 13US FAERS
110ErythemaFAERS: 13US FAERS
111Impaired work abilityFAERS: 13US FAERS
112InfectionFAERS: 13US FAERS
113InfertilityFAERS: 13US FAERS
114Intentional product use issueFAERS: 13US FAERS
115Nipple painFAERS: 13US FAERS
116Optic NeuritisFAERS: 13US FAERS
117Pulmonary HypertensionFAERS: 13US FAERS
118SarcoidosisFAERS: 13US FAERS
119Suppressed lactationFAERS: 13US FAERS
120Vaginal mycosisFAERS: 13US FAERS
121Abdominal discomfortFAERS: 12US FAERS
122Blood cholesterol increasedFAERS: 12US FAERS
123CystitisFAERS: 12US FAERS
124Dry skinFAERS: 12US FAERS
125Fibrin D dimer increasedFAERS: 12US FAERS
126Hypertensive heart diseaseFAERS: 12US FAERS
127Retinal Artery OcclusionFAERS: 12US FAERS
128SomnolenceFAERS: 12US FAERS
129Sudden deathFAERS: 12US FAERS
130Application site erosionFAERS: 11US FAERS
131CryingFAERS: 11US FAERS
132EndometriosisFAERS: 11US FAERS
133Hypertensive crisisFAERS: 11US FAERS
134NephrolithiasisFAERS: 11US FAERS
135Pelvic PainFAERS: 11US FAERS
136PharyngitisFAERS: 11US FAERS
137RetchingFAERS: 11US FAERS
138Septic embolusFAERS: 11US FAERS
139Supraventricular tachycardiaFAERS: 11US FAERS
140Application site discomfortFAERS: 10US FAERS
141Blighted ovumFAERS: 10US FAERS
142BlindnessFAERS: 10US FAERS
143Breast CystFAERS: 10US FAERS
144Burning sensationFAERS: 10US FAERS
145Carotid artery aneurysmFAERS: 10US FAERS
146HyperventilationFAERS: 10US FAERS
147Incorrect product storageFAERS: 10US FAERS
148Joint swellingFAERS: 10US FAERS
149LethargyFAERS: 10US FAERS
150Neck PainFAERS: 10US FAERS
151NervousnessFAERS: 10US FAERS
152Pelvic Inflammatory DiseaseFAERS: 10US FAERS
153Product packaging issueFAERS: 10US FAERS
154Unexpected therapeutic drug effectFAERS: 10US FAERS
155Vulvovaginal drynessFAERS: 10US FAERS
156Adnexa uteri painFAERS: 9US FAERS
157Application site pigmentation changesFAERS: 9US FAERS
158Application site swellingFAERS: 9US FAERS
159Arterial thrombosisFAERS: 9US FAERS
160Blood urine presentFAERS: 9US FAERS
161Breast discomfortFAERS: 9US FAERS
162CellulitisFAERS: 9US FAERS
163Drug exposure before pregnancyFAERS: 9US FAERS
164DystoniaFAERS: 9US FAERS
165Feeling ColdFAERS: 9US FAERS
166GastroenteritisFAERS: 9US FAERS
167Night sweatsFAERS: 9US FAERS
168Splenic InfarctionFAERS: 9US FAERS
169SwellingFAERS: 9US FAERS
170Vulvovaginal discomfortFAERS: 9US FAERS
171AbasiaFAERS: 8US FAERS
172AneurysmFAERS: 8US FAERS
173Application site photosensitivity reactionFAERS: 8US FAERS
174ArteriosclerosisFAERS: 8US FAERS
175Cerebral artery occlusionFAERS: 8US FAERS
176Hypoaesthesia facialFAERS: 8US FAERS
177LymphadenopathyFAERS: 8US FAERS
178Pelvic venous thrombosisFAERS: 8US FAERS
179Poor quality drug administeredFAERS: 8US FAERS
180StressFAERS: 8US FAERS
181Thyroid NeoplasmFAERS: 8US FAERS
182Transaminases increasedFAERS: 8US FAERS
183Anoxic EncephalopathyFAERS: 7US FAERS
184Application site hypersensitivityFAERS: 7US FAERS
185Application site vesiclesFAERS: 7US FAERS
186ChromaturiaFAERS: 7US FAERS
187Complications of maternal exposure to therapeutic drugsFAERS: 7US FAERS
188Depressed Level of ConsciousnessFAERS: 7US FAERS
189DysgeusiaFAERS: 7US FAERS
190DyspareuniaFAERS: 7US FAERS
191EpilepsyFAERS: 7US FAERS
192FlatulenceFAERS: 7US FAERS
193HypothyroidismFAERS: 7US FAERS
194OsteomyelitisFAERS: 7US FAERS
195Peripheral embolismFAERS: 7US FAERS
196PleurisyFAERS: 7US FAERS
197PresyncopeFAERS: 7US FAERS
198Respiratory arrestFAERS: 7US FAERS
199SepsisFAERS: 7US FAERS
200Skin reactionFAERS: 7US FAERS
201TorticollisFAERS: 7US FAERS
202Venous stenosisFAERS: 7US FAERS
203Visual ImpairmentFAERS: 7US FAERS
204furuncleFAERS: 7US FAERS
205Accidental exposure to productFAERS: 6US FAERS
206AmnesiaFAERS: 6US FAERS
207Aspartate Aminotransferase IncreasedFAERS: 6US FAERS
208Brain DeathFAERS: 6US FAERS
209Central nervous system lesionFAERS: 6US FAERS
210Cold sweatFAERS: 6US FAERS
211CystFAERS: 6US FAERS
212Embolic strokeFAERS: 6US FAERS
213Eye painFAERS: 6US FAERS
214Gestational DiabetesFAERS: 6US FAERS
215Hormone level abnormalFAERS: 6US FAERS
216HydrocephalusFAERS: 6US FAERS
217InflammationFAERS: 6US FAERS
218Maternal exposure during pregnancyFAERS: 6US FAERS
219Multiple SclerosisFAERS: 6US FAERS
220Muscle abscessFAERS: 6US FAERS
221Muscle strainFAERS: 6US FAERS
222Muscle tightnessFAERS: 6US FAERS
223Musculoskeletal PainFAERS: 6US FAERS
224Musculoskeletal chest painFAERS: 6US FAERS
225Musculoskeletal stiffnessFAERS: 6US FAERS
226Perirectal abscessFAERS: 6US FAERS
227PhlebitisFAERS: 6US FAERS
228PhotophobiaFAERS: 6US FAERS
229Post procedural complicationFAERS: 6US FAERS
230Pregnancy on oral contraceptiveFAERS: 6US FAERS
231PyomyositisFAERS: 6US FAERS
232Rash erythematousFAERS: 6US FAERS
233Respiratory distressFAERS: 6US FAERS
234Right ventricular failureFAERS: 6US FAERS
235SalpingectomyFAERS: 6US FAERS
236Secretion dischargeFAERS: 6US FAERS
237Systemic Inflammatory Response SyndromeFAERS: 6US FAERS
238ThrombocytopeniaFAERS: 6US FAERS
239Vaginal lesionFAERS: 6US FAERS
240Venous thrombosis limbFAERS: 6US FAERS
241Alanine Aminotransferase IncreasedFAERS: 5US FAERS
242Anaphylactic shockFAERS: 5US FAERS
243Blood glucose increasedFAERS: 5US FAERS
244Bone painFAERS: 5US FAERS
245BradycardiaFAERS: 5US FAERS
246Cardiac enzymes increasedFAERS: 5US FAERS
247Cervical dysplasiaFAERS: 5US FAERS
248Cervix carcinomaFAERS: 5US FAERS
249CholecystitisFAERS: 5US FAERS
250Disease recurrenceFAERS: 5US FAERS
251Eye irritationFAERS: 5US FAERS
252GastritisFAERS: 5US FAERS
253HypoxiaFAERS: 5US FAERS
254Intracranial AneurysmFAERS: 5US FAERS
255LeukopeniaFAERS: 5US FAERS
256Malignant HypertensionFAERS: 5US FAERS
257Musculoskeletal discomfortFAERS: 5US FAERS
258MyocarditisFAERS: 5US FAERS
259PeritonitisFAERS: 5US FAERS
260Pregnancy test positiveFAERS: 5US FAERS
261Product outer packaging issueFAERS: 5US FAERS
262Ruptured ectopic pregnancyFAERS: 5US FAERS
263Septic phlebitisFAERS: 5US FAERS
264Therapy cessationFAERS: 5US FAERS
265ThrombophlebitisFAERS: 5US FAERS
266VaginitisFAERS: 5US FAERS
267Abnormal withdrawal bleedingFAERS: 4US FAERS
268Activities of daily living impairedFAERS: 4US FAERS
269Acute respiratory failureFAERS: 4US FAERS
270AgitationFAERS: 4US FAERS
271AppendicitisFAERS: 4US FAERS
272Application site drynessFAERS: 4US FAERS
273ArthritisFAERS: 4US FAERS
274Blood lactate dehydrogenase increasedFAERS: 4US FAERS
275Cardiac valve replacement complicationFAERS: 4US FAERS
276DermatitisFAERS: 4US FAERS
277DiscomfortFAERS: 4US FAERS
278EncephalitisFAERS: 4US FAERS
279Erythema NodosumFAERS: 4US FAERS
280FrustrationFAERS: 4US FAERS
281GlaucomaFAERS: 4US FAERS
282HemiparesisFAERS: 4US FAERS
283HepatitisFAERS: 4US FAERS
284HungerFAERS: 4US FAERS
285HyperthyroidismFAERS: 4US FAERS
286HypotrichosisFAERS: 4US FAERS
287Impaired driving abilityFAERS: 4US FAERS
288Incorrect route of drug administrationFAERS: 4US FAERS
289Intentional drug misuseFAERS: 4US FAERS
290Lactation DisorderFAERS: 4US FAERS
291LymphostasisFAERS: 4US FAERS
292Mediastinal massFAERS: 4US FAERS
293Peripheral swellingFAERS: 4US FAERS
294Pleuritic painFAERS: 4US FAERS
295Pre-EclampsiaFAERS: 4US FAERS
296Protein S decreasedFAERS: 4US FAERS
297Pulmonary EosinophiliaFAERS: 4US FAERS
298Retropharyngeal AbscessFAERS: 4US FAERS
299SneezingFAERS: 4US FAERS
300Sudden Cardiac DeathFAERS: 4US FAERS
301Thromboembolic strokeFAERS: 4US FAERS
302TinnitusFAERS: 4US FAERS
303Unresponsive to stimuliFAERS: 4US FAERS
304Vaginal painFAERS: 4US FAERS
305VasculitisFAERS: 4US FAERS
306jaundiceFAERS: 4US FAERS
307nervous system disorderFAERS: 4US FAERS
308AbscessFAERS: 3US FAERS
309Accidental exposureFAERS: 3US FAERS
310Application site exfoliationFAERS: 3US FAERS
311Application site inflammationFAERS: 3US FAERS
312Application site scabFAERS: 3US FAERS
313Bipolar DisorderFAERS: 3US FAERS
314Blood potassium increasedFAERS: 3US FAERS
315Blood triglycerides increasedFAERS: 3US FAERS
316CardiomegalyFAERS: 3US FAERS
317Caustic injuryFAERS: 3US FAERS
318Cerebellar infarctionFAERS: 3US FAERS
319Cerebral ventricle dilatationFAERS: 3US FAERS
320Coagulation factor VIII level increasedFAERS: 3US FAERS
321Complex partial seizuresFAERS: 3US FAERS
322ConjunctivitisFAERS: 3US FAERS
323Conversion disorderFAERS: 3US FAERS
324CyanosisFAERS: 3US FAERS
325Device FailureFAERS: 3US FAERS
326DiplopiaFAERS: 3US FAERS
327Drug dispensing errorFAERS: 3US FAERS
328DysarthriaFAERS: 3US FAERS
329Electromechanical dissociationFAERS: 3US FAERS
330Endometrial hypertrophyFAERS: 3US FAERS
331Escherichia urinary tract infectionFAERS: 3US FAERS
332Feeling jitteryFAERS: 3US FAERS
333Flank PainFAERS: 3US FAERS
334FlushingFAERS: 3US FAERS
335Focal Nodular HyperplasiaFAERS: 3US FAERS
336Genital HerpesFAERS: 3US FAERS
337HemiplegiaFAERS: 3US FAERS
338HypersomniaFAERS: 3US FAERS
339HysterectomyFAERS: 3US FAERS
340Intentional misuseFAERS: 3US FAERS
341Intercepted medication errorFAERS: 3US FAERS
342Irritable Bowel SyndromeFAERS: 3US FAERS
343Keratoconjunctivitis SiccaFAERS: 3US FAERS
344Leukocytoclastic vasculitisFAERS: 3US FAERS
345Lung consolidationFAERS: 3US FAERS
346Memory impairmentFAERS: 3US FAERS
347Mental status changesFAERS: 3US FAERS
348MetaplasiaFAERS: 3US FAERS
349Migraine with AuraFAERS: 3US FAERS
350Muscle RigidityFAERS: 3US FAERS
351MydriasisFAERS: 3US FAERS
352Nephrotic SyndromeFAERS: 3US FAERS
353PallorFAERS: 3US FAERS
354PneumothoraxFAERS: 3US FAERS
355Renal ColicFAERS: 3US FAERS
356Respiratory tract congestionFAERS: 3US FAERS
357RosaceaFAERS: 3US FAERS
358ShockFAERS: 3US FAERS
359Splenic vein thrombosisFAERS: 3US FAERS
360StrabismusFAERS: 3US FAERS
361Temperature intoleranceFAERS: 3US FAERS
362Thermal burnFAERS: 3US FAERS
363TrichorrhexisFAERS: 3US FAERS
364Vaginal burning sensationFAERS: 3US FAERS
365Vein painFAERS: 3US FAERS
366Vulvovaginal pruritusFAERS: 3US FAERS
367White blood cell count decreasedFAERS: 3US FAERS
368ovarian neoplasmFAERS: 3US FAERS
369Acute psychosisFAERS: 2US FAERS
370Adnexa uteri massFAERS: 2US FAERS
371Amphetamines positiveFAERS: 2US FAERS
372AngerFAERS: 2US FAERS
373Angina PectorisFAERS: 2US FAERS
374Anti-SS-A antibody positiveFAERS: 2US FAERS
375Anti-thyroid antibody positiveFAERS: 2US FAERS
376Antiphospholipid SyndromeFAERS: 2US FAERS
377Antithrombin III decreasedFAERS: 2US FAERS
378AphagiaFAERS: 2US FAERS
379Application site papulesFAERS: 2US FAERS
380Application site ulcerFAERS: 2US FAERS
381Application site warmthFAERS: 2US FAERS
382ArthropathyFAERS: 2US FAERS
383Arthropod biteFAERS: 2US FAERS
384Autoimmune thrombocytopeniaFAERS: 2US FAERS
385Basilar artery thrombosisFAERS: 2US FAERS
386Bladder painFAERS: 2US FAERS
387Blood alkaline phosphatase increasedFAERS: 2US FAERS
388Blood catecholamines abnormalFAERS: 2US FAERS
389Blood glucose abnormalFAERS: 2US FAERS
390Blood glucose decreasedFAERS: 2US FAERS
391Blood homocysteine decreasedFAERS: 2US FAERS
392Blood iron decreasedFAERS: 2US FAERS
393Blood pressure fluctuationFAERS: 2US FAERS
394CalcinosisFAERS: 2US FAERS
395Cardiac FlutterFAERS: 2US FAERS
396Carotid artery occlusionFAERS: 2US FAERS
397Cerebral PalsyFAERS: 2US FAERS
398CholestasisFAERS: 2US FAERS
399Coagulation factor XII level increasedFAERS: 2US FAERS
400Counterfeit product administeredFAERS: 2US FAERS
401Disseminated Intravascular CoagulationFAERS: 2US FAERS
402Drug ineffective for unapproved indicationFAERS: 2US FAERS
403Drug toxicityFAERS: 2US FAERS
404Drug withdrawal syndromeFAERS: 2US FAERS
405Ear discomfortFAERS: 2US FAERS
406EcchymosisFAERS: 2US FAERS
407Economic problemFAERS: 2US FAERS
408EczemaFAERS: 2US FAERS
409EncephalomalaciaFAERS: 2US FAERS
410EndocarditisFAERS: 2US FAERS
411EructationFAERS: 2US FAERS
412ExcoriationFAERS: 2US FAERS
413Eye inflammationFAERS: 2US FAERS
414Facial ParesisFAERS: 2US FAERS
415Feeling of body temperature changeFAERS: 2US FAERS
416Fibroadenoma of breastFAERS: 2US FAERS
417Fluid overloadFAERS: 2US FAERS
418Food AllergyFAERS: 2US FAERS
419FormicationFAERS: 2US FAERS
420Gastric ulcerFAERS: 2US FAERS
421Gastrointestinal infectionFAERS: 2US FAERS
422HepatomegalyFAERS: 2US FAERS
423HepatosplenomegalyFAERS: 2US FAERS
424Hilar lymphadenopathyFAERS: 2US FAERS
425HoarsenessFAERS: 2US FAERS
426HyperacusisFAERS: 2US FAERS
427Hyperplastic cholecystopathyFAERS: 2US FAERS
428Inadequate lubricationFAERS: 2US FAERS
429Incorrect dose administeredFAERS: 2US FAERS
430InfarctionFAERS: 2US FAERS
431Joint Range of Motion DecreasedFAERS: 2US FAERS
432Joint injuryFAERS: 2US FAERS
433LabyrinthitisFAERS: 2US FAERS
434LeukocytosisFAERS: 2US FAERS
435Limb discomfortFAERS: 2US FAERS
436Limb injuryFAERS: 2US FAERS
437Lipase increasedFAERS: 2US FAERS
438Low birth weight babyFAERS: 2US FAERS
439Low density lipoprotein increasedFAERS: 2US FAERS
440LymphangioleiomyomatosisFAERS: 2US FAERS
441Neutrophil percentage decreasedFAERS: 2US FAERS
442No adverse effectFAERS: 2US FAERS
443NocturiaFAERS: 2US FAERS
444Nonspecific reactionFAERS: 2US FAERS
445NystagmusFAERS: 2US FAERS
446Obesity surgeryFAERS: 2US FAERS
447OligohydramniosFAERS: 2US FAERS
448Oropharyngeal painFAERS: 2US FAERS
449Otitis MediaFAERS: 2US FAERS
450Ovarian enlargementFAERS: 2US FAERS
451Pancreatic enzymes increasedFAERS: 2US FAERS
452Personality ChangeFAERS: 2US FAERS
453PetechiaeFAERS: 2US FAERS
454Pharyngolaryngeal PainFAERS: 2US FAERS
455Poor peripheral circulationFAERS: 2US FAERS
456Precancerous cells presentFAERS: 2US FAERS
457Pregnancy with contraceptive deviceFAERS: 2US FAERS
458Product counterfeitFAERS: 2US FAERS
459Product formulation issueFAERS: 2US FAERS
460Product label issueFAERS: 2US FAERS
461Pseudomyxoma PeritoneiFAERS: 2US FAERS
462Pulmonary congestionFAERS: 2US FAERS
463SchizophreniaFAERS: 2US FAERS
464SclerodermaFAERS: 2US FAERS
465Shoulder PainFAERS: 2US FAERS
466Simple Partial SeizuresFAERS: 2US FAERS
467Skin PapillomaFAERS: 2US FAERS
468Skin UlcerFAERS: 2US FAERS
469Skin lacerationFAERS: 2US FAERS
470Somatoform DisorderFAERS: 2US FAERS
471Status EpilepticusFAERS: 2US FAERS
472Subcutaneous AbscessFAERS: 2US FAERS
473SunburnFAERS: 2US FAERS
474Suspected counterfeit productFAERS: 2US FAERS
475SympathectomyFAERS: 2US FAERS
476Synovial CystFAERS: 2US FAERS
477Throat irritationFAERS: 2US FAERS
478ThrombocytosisFAERS: 2US FAERS
479Thrombotic strokeFAERS: 2US FAERS
480Tooth InfectionFAERS: 2US FAERS
481Total cholesterol/HDL ratio decreasedFAERS: 2US FAERS
482Toxic Shock SyndromeFAERS: 2US FAERS
483TracheobronchitisFAERS: 2US FAERS
484Unwanted pregnancyFAERS: 2US FAERS
485Urethral cystFAERS: 2US FAERS
486Vaginal hysterectomyFAERS: 2US FAERS
487Vascular occlusionFAERS: 2US FAERS
488Vascular ruptureFAERS: 2US FAERS
489Venous occlusionFAERS: 2US FAERS
490Vitamin D DeficiencyFAERS: 2US FAERS
491Vitreous DetachmentFAERS: 2US FAERS
492Abdominal massFAERS: 1US FAERS
493Abdominal symptomFAERS: 1US FAERS
494Abdominal tendernessFAERS: 1US FAERS
495Abnormal weight gainFAERS: 1US FAERS
496AcarodermatitisFAERS: 1US FAERS
497Accidental drug intake by childFAERS: 1US FAERS
498Activated protein C resistance test positiveFAERS: 1US FAERS
499Administration site rashFAERS: 1US FAERS
500Adrenal massFAERS: 1US FAERS
501AgeusiaFAERS: 1US FAERS
502Agonal death struggleFAERS: 1US FAERS
503Alopecia AreataFAERS: 1US FAERS
504Amaurosis FugaxFAERS: 1US FAERS
505AnhedoniaFAERS: 1US FAERS
506Ankylosing spondylitisFAERS: 1US FAERS
507Anorectal operationFAERS: 1US FAERS
508AnosmiaFAERS: 1US FAERS
509Antiphospholipid antibodies positiveFAERS: 1US FAERS
510Antithrombin III increasedFAERS: 1US FAERS
511AphoniaFAERS: 1US FAERS
512Application site acneFAERS: 1US FAERS
513Application site dischargeFAERS: 1US FAERS
514Application site excoriationFAERS: 1US FAERS
515Application site lacerationFAERS: 1US FAERS
516Application site massFAERS: 1US FAERS
517Application site noduleFAERS: 1US FAERS
518Application site pustulesFAERS: 1US FAERS
519Application site urticariaFAERS: 1US FAERS
520AscitesFAERS: 1US FAERS
521AsthenopiaFAERS: 1US FAERS
522Atrial FlutterFAERS: 1US FAERS
523Atrophic vulvovaginitisFAERS: 1US FAERS
524AuraFAERS: 1US FAERS
525Autoimmune hepatitisFAERS: 1US FAERS
526Autoimmune thyroiditisFAERS: 1US FAERS
527Back disorderFAERS: 1US FAERS
528Bacterial VaginosisFAERS: 1US FAERS
529BalanitisFAERS: 1US FAERS
530Basal cell carcinomaFAERS: 1US FAERS
531BedriddenFAERS: 1US FAERS
532Biliary ColicFAERS: 1US FAERS
533Biliary DyskinesiaFAERS: 1US FAERS
534Bipolar I disorderFAERS: 1US FAERS
535Bladder discomfortFAERS: 1US FAERS
536Bladder spasmFAERS: 1US FAERS
537Blood PressureFAERS: 1US FAERS
538Blood albumin decreasedFAERS: 1US FAERS
539Blood amylase increasedFAERS: 1US FAERS
540Blood cholesterol abnormalFAERS: 1US FAERS
541Blood cholesterolFAERS: 1US FAERS
542Blood cortisol increasedFAERS: 1US FAERS
543Blood count abnormalFAERS: 1US FAERS
544Blood fibrinogen increasedFAERS: 1US FAERS
545Blood immunoglobulin E increasedFAERS: 1US FAERS
546Blood parathyroid hormone increasedFAERS: 1US FAERS
547Blood potassium decreasedFAERS: 1US FAERS
548Blood prolactin increasedFAERS: 1US FAERS
549Blood triglycerides abnormalFAERS: 1US FAERS
550Body fat disorderFAERS: 1US FAERS
551Brachial plexus lesionFAERS: 1US FAERS
552Breast fibromaFAERS: 1US FAERS
553Bronchopleural FistulaFAERS: 1US FAERS
554BronchospasmFAERS: 1US FAERS
555Bunion operationFAERS: 1US FAERS
556Calcium deficiencyFAERS: 1US FAERS
557CandidiasisFAERS: 1US FAERS
558CarcinomaFAERS: 1US FAERS
559Cardiovascular insufficiencyFAERS: 1US FAERS
560Carpal Tunnel SyndromeFAERS: 1US FAERS
561Catheter sepsisFAERS: 1US FAERS
562Cavernous Sinus ThrombosisFAERS: 1US FAERS
563Cerebral disorderFAERS: 1US FAERS
564Cervical polypFAERS: 1US FAERS
565Chest wall painFAERS: 1US FAERS
566ChokingFAERS: 1US FAERS
567CholangitisFAERS: 1US FAERS
568Cleft PalateFAERS: 1US FAERS
569Coagulation factor IX level increasedFAERS: 1US FAERS
570Coagulation factor XIII level decreasedFAERS: 1US FAERS
571Coital bleedingFAERS: 1US FAERS
572Colonic StenosisFAERS: 1US FAERS
573Completed SuicideFAERS: 1US FAERS
574Concomitant disease aggravatedFAERS: 1US FAERS
575Contact lens complicationFAERS: 1US FAERS
576Cyst removalFAERS: 1US FAERS
577DemyelinationFAERS: 1US FAERS
578Dengue FeverFAERS: 1US FAERS
579Dental cariesFAERS: 1US FAERS
580Depression suicidalFAERS: 1US FAERS
581Dermoid CystFAERS: 1US FAERS
582Disease ProgressionFAERS: 1US FAERS
583DisorientationFAERS: 1US FAERS
584Drug DependenceFAERS: 1US FAERS
585Drug screen positiveFAERS: 1US FAERS
586DysphasiaFAERS: 1US FAERS
587DysphoniaFAERS: 1US FAERS
588Echocardiogram abnormalFAERS: 1US FAERS
589Ejection Fraction DecreasedFAERS: 1US FAERS
590Electrocardiogram ST-T segment abnormalFAERS: 1US FAERS
591Electrocardiogram abnormalFAERS: 1US FAERS
592Emotional distressFAERS: 1US FAERS
593EmpyemaFAERS: 1US FAERS
594EpistaxisFAERS: 1US FAERS
595Essential HypertensionFAERS: 1US FAERS
596Expired drug administeredFAERS: 1US FAERS
597Exposure during breast feedingFAERS: 1US FAERS
598Extraocular Muscle ParesisFAERS: 1US FAERS
599Eye RednessFAERS: 1US FAERS
600Facial PainFAERS: 1US FAERS
601Fallopian tube obstructionFAERS: 1US FAERS
602FasciitisFAERS: 1US FAERS
603Female Orgasmic DisorderFAERS: 1US FAERS
604FibromatosisFAERS: 1US FAERS
605Flight of ideasFAERS: 1US FAERS
606Food PoisoningFAERS: 1US FAERS
607Gardnerella test positiveFAERS: 1US FAERS
608Gastrointestinal PainFAERS: 1US FAERS
609General physical condition abnormalFAERS: 1US FAERS
610Genital dischargeFAERS: 1US FAERS
611Genital painFAERS: 1US FAERS
612GliosisFAERS: 1US FAERS
613GlossitisFAERS: 1US FAERS
614GranulomaFAERS: 1US FAERS
615HELLP SyndromeFAERS: 1US FAERS
616HaematinuriaFAERS: 1US FAERS
617Heart valve calcificationFAERS: 1US FAERS
618Heat StrokeFAERS: 1US FAERS
619Hepatic Vein ThrombosisFAERS: 1US FAERS
620Hepatic congestionFAERS: 1US FAERS
621HirsutismFAERS: 1US FAERS
622Human chorionic gonadotropin positiveFAERS: 1US FAERS
623HydropneumothoraxFAERS: 1US FAERS
624HyperplasiaFAERS: 1US FAERS
625HypertrichosisFAERS: 1US FAERS
626HypokinesiaFAERS: 1US FAERS
627HypospadiasFAERS: 1US FAERS
628HypoventilationFAERS: 1US FAERS
629IleusFAERS: 1US FAERS
630ImmobileFAERS: 1US FAERS
631Impaired gastric emptyingFAERS: 1US FAERS
632Incision site infectionFAERS: 1US FAERS
633IncontinenceFAERS: 1US FAERS
634Incorrect storage of drugFAERS: 1US FAERS
635Increased upper airway secretionFAERS: 1US FAERS
636Infusion site painFAERS: 1US FAERS
637Initial insomniaFAERS: 1US FAERS
638Intentional product misuseFAERS: 1US FAERS
639Intestinal ObstructionFAERS: 1US FAERS
640Intestinal PerforationFAERS: 1US FAERS
641Investigation abnormalFAERS: 1US FAERS
642IritisFAERS: 1US FAERS
643Irregular sleep phaseFAERS: 1US FAERS
644Joint sprainFAERS: 1US FAERS
645KeratitisFAERS: 1US FAERS
646LacerationFAERS: 1US FAERS
647Lactose IntoleranceFAERS: 1US FAERS
648Large intestine perforationFAERS: 1US FAERS
649Latex allergyFAERS: 1US FAERS
650LazinessFAERS: 1US FAERS
651Left Ventricular HypertrophyFAERS: 1US FAERS
652LentigoFAERS: 1US FAERS
653Lip swellingFAERS: 1US FAERS
654Lobar PneumoniaFAERS: 1US FAERS
655Localised skin reactionFAERS: 1US FAERS
656Lung AbscessFAERS: 1US FAERS
657Lung InjuryFAERS: 1US FAERS
658Lyme DiseaseFAERS: 1US FAERS
659Markedly reduced dietary intakeFAERS: 1US FAERS
660MastitisFAERS: 1US FAERS
661Medical device removalFAERS: 1US FAERS
662MeningitisFAERS: 1US FAERS
663Mental impairmentFAERS: 1US FAERS
664Metabolic acidosisFAERS: 1US FAERS
665MiliariaFAERS: 1US FAERS
666MonocytosisFAERS: 1US FAERS
667MonoparesisFAERS: 1US FAERS
668Motion SicknessFAERS: 1US FAERS
669Multiple allergiesFAERS: 1US FAERS
670Multiple sclerosis relapseFAERS: 1US FAERS
671Murphy's sign positiveFAERS: 1US FAERS
672MyomectomyFAERS: 1US FAERS
673NarcolepsyFAERS: 1US FAERS
674Nasal discomfortFAERS: 1US FAERS
675Neurological examination abnormalFAERS: 1US FAERS
676No adverse drug reactionFAERS: 1US FAERS
677No adverse reactionFAERS: 1US FAERS
678No reaction on previous exposure to drugFAERS: 1US FAERS
679Ocular HypertensionFAERS: 1US FAERS
680Ocular discomfortFAERS: 1US FAERS
681Ocular vascular disorderFAERS: 1US FAERS
682OnychoclasisFAERS: 1US FAERS
683OnychomycosisFAERS: 1US FAERS
684Open woundFAERS: 1US FAERS
685Oral painFAERS: 1US FAERS
686Orgasmic sensation decreasedFAERS: 1US FAERS
687OsteitisFAERS: 1US FAERS
688Otitis ExternaFAERS: 1US FAERS
689OtosclerosisFAERS: 1US FAERS
690Ovarian Hyperstimulation SyndromeFAERS: 1US FAERS
691Ovarian vein thrombosisFAERS: 1US FAERS
692OverdoseFAERS: 1US FAERS
693Ovulation disorderFAERS: 1US FAERS
694PCO2 decreasedFAERS: 1US FAERS
695Pain of skinFAERS: 1US FAERS
696Panic DisorderFAERS: 1US FAERS
697ParanoiaFAERS: 1US FAERS
698Parasitic gastroenteritisFAERS: 1US FAERS
699Performance status decreasedFAERS: 1US FAERS
700Peripartum cardiomyopathyFAERS: 1US FAERS
701Peripheral nerve palsyFAERS: 1US FAERS
702Peritonsillar AbscessFAERS: 1US FAERS
703Phantom painFAERS: 1US FAERS
704PhonophobiaFAERS: 1US FAERS
705Placental InsufficiencyFAERS: 1US FAERS
706PneumocephalusFAERS: 1US FAERS
707PneumonitisFAERS: 1US FAERS
708PoisoningFAERS: 1US FAERS
709PolyarthritisFAERS: 1US FAERS
710PolydactylyFAERS: 1US FAERS
711PolydipsiaFAERS: 1US FAERS
712PolyneuropathyFAERS: 1US FAERS
713PolyuriaFAERS: 1US FAERS
714Post lumbar puncture syndromeFAERS: 1US FAERS
715Pregnancy on contraceptiveFAERS: 1US FAERS
716Pregnancy with injectable contraceptiveFAERS: 1US FAERS
717Premenstrual crampsFAERS: 1US FAERS
718Procedural complicationFAERS: 1US FAERS
719Product complaintFAERS: 1US FAERS
720Product label confusionFAERS: 1US FAERS
721Product lot number issueFAERS: 1US FAERS
722Product physical issueFAERS: 1US FAERS
723Product size issueFAERS: 1US FAERS
724Product use in unapproved indicationFAERS: 1US FAERS
725Protein C increasedFAERS: 1US FAERS
726Protein S DeficiencyFAERS: 1US FAERS
727Protein total decreasedFAERS: 1US FAERS
728Protein total increasedFAERS: 1US FAERS
729Protein urine presentFAERS: 1US FAERS
730Prothrombin time abnormalFAERS: 1US FAERS
731PsoriasisFAERS: 1US FAERS
732Psychiatric symptomFAERS: 1US FAERS
733Pulmonary artery thrombosisFAERS: 1US FAERS
734PyelonephritisFAERS: 1US FAERS
735Pyoderma GangrenosumFAERS: 1US FAERS
736Rectal polypFAERS: 1US FAERS
737Renal cystFAERS: 1US FAERS
738Respiratory fremitusFAERS: 1US FAERS
739Respiratory tract irritationFAERS: 1US FAERS
740RestlessnessFAERS: 1US FAERS
741Retinal DetachmentFAERS: 1US FAERS
742Retinal vascular occlusionFAERS: 1US FAERS
743Retinal vascular thrombosisFAERS: 1US FAERS
744Rheumatoid ArthritisFAERS: 1US FAERS
745Ruptured cerebral aneurysmFAERS: 1US FAERS
746SalpingitisFAERS: 1US FAERS
747Salpingo-oophorectomyFAERS: 1US FAERS
748ScotomaFAERS: 1US FAERS
749Septic ShockFAERS: 1US FAERS
750SeptoplastyFAERS: 1US FAERS
751Sexual DysfunctionFAERS: 1US FAERS
752Sinus ArrhythmiaFAERS: 1US FAERS
753Sinus TachycardiaFAERS: 1US FAERS
754Sjogren's SyndromeFAERS: 1US FAERS
755Skin ErosionFAERS: 1US FAERS
756Skin discomfortFAERS: 1US FAERS
757SluggishnessFAERS: 1US FAERS
758Sputum culture positiveFAERS: 1US FAERS
759StillbirthFAERS: 1US FAERS
760Subclavian artery thrombosisFAERS: 1US FAERS
761Subcutaneous EmphysemaFAERS: 1US FAERS
762Sudden infant death syndromeFAERS: 1US FAERS
763SuperovulationFAERS: 1US FAERS
764TachyphreniaFAERS: 1US FAERS
765Tension HeadacheFAERS: 1US FAERS
766TeratomaFAERS: 1US FAERS
767Thalamic infarctionFAERS: 1US FAERS
768Therapeutic procedureFAERS: 1US FAERS
769ThirstFAERS: 1US FAERS
770ThyroidectomyFAERS: 1US FAERS
771Tongue bitingFAERS: 1US FAERS
772TonsillectomyFAERS: 1US FAERS
773ToothacheFAERS: 1US FAERS
774Toxicity to various agentsFAERS: 1US FAERS
775Transdermal contraceptionFAERS: 1US FAERS
776Traumatic Brain InjuryFAERS: 1US FAERS
777Trigeminal NeuralgiaFAERS: 1US FAERS
778Trisomy 21FAERS: 1US FAERS
779TuberculosisFAERS: 1US FAERS
780Ubiquinone decreasedFAERS: 1US FAERS
781Umbilical herniaFAERS: 1US FAERS
782Uterine CancerFAERS: 1US FAERS
783Uterine PolypFAERS: 1US FAERS
784UveitisFAERS: 1US FAERS
785Vaginal ProlapseFAERS: 1US FAERS
786Vascular compressionFAERS: 1US FAERS
787Venous InsufficiencyFAERS: 1US FAERS
788Venous angioma of brainFAERS: 1US FAERS
789Ventricular hypokinesiaFAERS: 1US FAERS
790VitiligoFAERS: 1US FAERS
791Vulvovaginal mycotic infectionFAERS: 1US FAERS
792Vulvovaginal swellingFAERS: 1US FAERS
793Walking aid userFAERS: 1US FAERS
794Withdrawal bleeding irregularFAERS: 1US FAERS
795Wolff-Parkinson-White SyndromeFAERS: 1US FAERS
796Wound InfectionFAERS: 1US FAERS
797Dysmenorrhea20931801CTD
798Venous Thromboembolism17586129CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.